Thompson Peter A.

CIK 1357522
Transactions on file
23
Open-market buys
3
Win rate (buys)
100%
3 scored
Avg % since filing (buys)
+121.8%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-07-092026-07-07SION
Sionna Therapeutics, Inc.
Director
Sale85,918$3.85M+1.2%open →
2026-07-022026-06-30SION
Sionna Therapeutics, Inc.
Director
Sale115,844$5.27M-0.3%open →
2026-05-302026-05-27SION
Sionna Therapeutics, Inc.
Director
Sale101$4.5K+2.0%open →
2026-05-112026-05-11SION
Sionna Therapeutics, Inc.
Director
Sale184,639$8.53M-1.8%open →
2026-05-112026-05-08SION
Sionna Therapeutics, Inc.
Director
Sale59,767$2.66M+1.8%open →
2026-05-112026-05-07SION
Sionna Therapeutics, Inc.
Director
Sale48,546$2.17M+1.7%open →
2026-04-212026-04-18SION
Sionna Therapeutics, Inc.
Director
Sale2,948$131.2K+1.9%open →
2026-04-212026-04-17SION
Sionna Therapeutics, Inc.
Director
Sale52,397$2.34M+1.6%open →
2026-04-162026-04-16SION
Sionna Therapeutics, Inc.
Director
Sale226,906$10.29M+0.1%open →
2026-04-162026-04-15SION
Sionna Therapeutics, Inc.
Director
Sale235,863$10.53M+1.7%open →
2026-04-162026-04-14SION
Sionna Therapeutics, Inc.
Director
Sale47,814$2.13M+2.0%open →
2025-02-102025-02-10SION
Sionna Therapeutics, Inc.
Director
C3,154,959open →
2025-02-102025-02-10SION
Sionna Therapeutics, Inc.
Director
Buy550,000$9.90M+152.1%open →
2025-04-042025-04-03EWTX
Edgewise Therapeutics, Inc.
Director10%
Buy124,193$2.50M+106.7%open →
2025-04-042025-04-03EWTX
Edgewise Therapeutics, Inc.
Director10%
Buy372,578$7.50M+106.7%open →
2025-12-192025-12-19SION
Sionna Therapeutics, Inc.
Director
Sale875$38.9K+2.0%open →
2025-12-192025-12-18SION
Sionna Therapeutics, Inc.
Director
Sale100$4.4K+2.0%open →
2025-12-192025-12-17SION
Sionna Therapeutics, Inc.
Director
Sale900$40.0K+2.0%open →
2025-11-262025-11-26SION
Sionna Therapeutics, Inc.
Director
Sale1,600$71.2K+2.0%open →
2025-11-262025-11-25SION
Sionna Therapeutics, Inc.
Director
Sale11,890$530.3K+1.7%open →
2025-11-262025-11-24SION
Sionna Therapeutics, Inc.
Director
Sale94,583$4.21M+1.9%open →
2025-07-012025-06-27CRVS
Corvus Pharmaceuticals, Inc.
Director10%
Sale1,176,332$4.89M+259.9%open →
2025-07-012025-06-27CRVS
Corvus Pharmaceuticals, Inc.
Director10%
X1,397,684$4.89M+327.7%open →